Latest filings (excl ownership)
15-12G
Securities registration termination
8 May 23
25-NSE
Exchange delisting
26 Apr 23
10-K
2022 FY
Annual report
13 Apr 23
8-K
Eucrates Biomedical Acquisition Corp. Announces Liquidation
11 Apr 23
8-K
Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
3 Apr 23
NT 10-K
Notice of late annual filing
29 Mar 23
8-K
Entry into a Material Definitive Agreement
16 Feb 23
10-Q
2022 Q3
Quarterly report
14 Nov 22
8-K
Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
8 Nov 22
8-K
Amendments to Articles of Incorporation or Bylaws
31 Oct 22
8-K
Submission of Matters to a Vote of Security Holders
24 Oct 22
DEF 14A
Definitive proxy
12 Oct 22
UPLOAD
Letter from SEC
12 Oct 22
PRER14A
Preliminary revised proxy
5 Oct 22
CORRESP
Correspondence with SEC
5 Oct 22
UPLOAD
Letter from SEC
4 Oct 22
PRE 14A
Preliminary proxy
28 Sep 22
10-Q
2022 Q2
Quarterly report
15 Aug 22
10-Q
2022 Q1
Quarterly report
23 May 22
NT 10-Q
Notice of late quarterly filing
16 May 22
10-K
2021 FY
Annual report
8 Apr 22
NT 10-K
Notice of late annual filing
31 Mar 22
8-K
Entry into a Material Definitive Agreement
26 Jan 22
10-K/A
2020 FY
Annual report (amended)
20 Dec 21
10-Q
2021 Q3
Quarterly report
22 Nov 21
8-K
Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review
19 Nov 21
NT 10-Q
Notice of late quarterly filing
16 Nov 21
10-Q
2021 Q2
Quarterly report
16 Aug 21
10-Q
2021 Q1
Quarterly report
16 Jul 21
10-K/A
2020 FY
Annual report (amended)
15 Jul 21
8-K
Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review
21 Jun 21
8-K
Eucrates Biomedical Acquisition Corp. Receives Expected Notice from Nasdaq Regarding Delayed Quarterly Report
1 Jun 21
NT 10-Q
Notice of late quarterly filing
17 May 21
10-K
2020 FY
Annual report
31 Mar 21
8-K
Announces the Separate Trading of its
14 Dec 20
10-Q
2020 Q3
Quarterly report
7 Dec 20
8-K
Eucrates Biomedical Acquisition Corporation
30 Nov 20
8-K
Index to Financial Statement
2 Nov 20
8-K
Other Events
28 Oct 20
424B4
Prospectus supplement with pricing info
26 Oct 20
Latest ownership filings
SC 13G/A
Flynn James E
10 Feb 23
SC 13G
BlackRock Inc.
9 Nov 22
SC 13G
PRICE T ROWE ASSOCIATES INC /MD/
14 Feb 22
SC 13G/A
BlackRock Inc.
8 Feb 22
SC 13G
Eucrates LLC
12 Feb 21
SC 13G
BlackRock Inc.
8 Feb 21
4
PARAG SAXENA
27 Nov 20
4
STELIOS PAPADOPOULOS
27 Nov 20
4
Change in insider ownership
27 Nov 20
SC 13G
Flynn James E
30 Oct 20
3
Evangelos Vergetis
23 Oct 20
3
Amitabh Singhal
23 Oct 20
3
Nina B. Shapiro
23 Oct 20
3
PARAG SAXENA
23 Oct 20
3
Shrikant Sathe
23 Oct 20
3
STELIOS PAPADOPOULOS
23 Oct 20
3
Daphne Karydas
23 Oct 20
3
Initial statement of insider ownership
23 Oct 20
3
Gonzalo Cordova
23 Oct 20
3
WILLIAM I CAMPBELL
23 Oct 20
3
Atanuu Agarrwal
23 Oct 20